News
On Thursday, AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus ...
Big-name bidders, strategic reviews, and PE exits define an active, high-stakes M&A market so far this summer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback